Middle meningeal artery embolization (MMAE) is a minimally invasive procedure used to treat chronic migraines and prevent complications from traumatic brain injuries (TBI). During MMAE, a catheter is inserted through a small incision in the groin, which is guided to the middle meningeal artery in the head. Tiny particles are then injected into the artery to block the blood flow to the brain’s pain-inducing areas or stop excessive bleeding after a brain injury. This procedure reduces migraine frequency and severity or prevents subdural hematomas, which can occur in TBI patients.
The procedure is performed under local anesthesia and involves no large incisions, allowing for quicker recovery compared to traditional surgical interventions.
Benefits of Middle Meningeal Artery Embolization
MMAE offers multiple benefits, especially for patients with chronic migraines or TBI. For migraine sufferers, it can provide long-term relief, reducing the frequency and intensity of headaches. It is especially beneficial for individuals who have not responded well to medications or other treatments. For patients with traumatic brain injuries, MMAE can help prevent complications like subdural hematomas, reducing the need for emergency surgeries and improving long-term outcomes. Because MMAE is minimally invasive, patients experience less pain and a faster recovery than they would from conventional surgery.
The procedure offers a non-surgical solution, which can be particularly appealing for patients looking to avoid extensive hospitalization and surgery.
Who Is a Candidate?
Candidates for MMAE include individuals suffering from chronic migraines that have not been relieved by traditional treatments, such as medications or nerve blocks. It is also recommended for patients who have sustained a traumatic brain injury and are at risk of developing subdural hematomas. The procedure is typically performed on adults, most commonly between the ages of 30 and 60, who have not found relief from conventional treatments. Every patient undergoes a comprehensive evaluation to determine whether MMAE is the right treatment based on their unique health needs and conditions.
If you are struggling with treatment-resistant migraines or a recent TBI, MMAE might be a suitable option to improve your quality of life.
What to Expect?
Middle meningeal artery embolization is typically performed under local anesthesia, and the procedure generally takes about one to two hours. After the procedure, you may experience mild headaches or soreness, but these symptoms usually resolve within a few days. Many patients begin to experience noticeable improvements in migraine frequency or intensity within a few weeks. In cases of TBI, patients are monitored for any changes and improvements in their condition over the following months. Post-procedure care involves minimal downtime, and most patients can return to their regular activities soon after.
Dr. Fabio Komlos ensures that the entire process, from the initial consultation to post-procedure recovery, is well-managed to achieve the best outcomes.
Why Choose Dr. Fabio Komlos?
Dr. Fabio Komlos is an experienced interventional radiologist who specializes in minimally invasive procedures, including MMAE. His expertise in performing image-guided treatments ensures precise delivery, maximizing the effectiveness of the procedure. Dr. Komlos prioritizes a personalized approach to each patient, ensuring that the treatment plan is tailored to address their specific condition and goals. With his commitment to using advanced techniques and providing compassionate care, Dr. Komlos is an excellent choice for patients seeking relief from chronic migraines or traumatic brain injury complications.
Take the Next Step
If you’re ready to explore MMAE for migraine relief or post-TBI complications, contact us to schedule a consultation and begin your journey to better health.